← Open Payments lookup

KAITLYN WILSON: Open Payments

NPI 1508550591 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,280 in 158 payments from 41 companies in 2025. Trend: 2023 $998 · 2024 $2,946 · 2025 $3,280

Food & beverage: $3,106Education: $174
CompanyPaymentsAmount
Janssen Biotech, Inc.16$451
AstraZeneca Pharmaceuticals LP15$294
PFIZER INC.13$175
Merck Sharp & Dohme LLC7$140
Genentech USA, Inc.6$130
Incyte Corporation7$128
Novartis Pharmaceuticals Corporation6$122
Daiichi Sankyo Inc.5$119
Exelixis Inc.5$107
GlaxoSmithKline, LLC.5$102

Products named: ENHERTU, DARZALEX, KEYTRUDA, CABOMETYX, CARVYKTI, ERLEADA, RYBREVANT, OPDIVO.

Industry payments across KS — which companies pay providers there.